Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Pak J Pharm Sci ; 37(1): 53-63, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38741400

RESUMEN

The study focused on the neuroprotective role of Sorghum bicolor and vitamin C in the amelioration of oxidative stress and anxiety-like behavoiur induced by tramadol in male albino rats. The study design involved 7 groups and a control group with 5 male albino rats in each group. Tramadol (40 mg/kg) treatment was administered for 21 days. Tramadol 40mg/kg was administered in all groups. Pretreatment with varying doses of Sorghum bicolor and Vitamin C was done in three of the groups. Behavioral assessment of anxiety and locomotors actions of the groups were compared using Elevated Plus Maze (EPM) and Open Field Test (OFT). In conclusion, Sorghum bicolor and Vitamin C tramadol ameliorated oxidative stress and anxiety-like behaviour induced by tramadol. Pretreatment with Sorghum bicolor or vitamin C (100mg) can also reduced anxiogenic responses in male albino rats that are induced by chronic tramadol use.


Asunto(s)
Ansiedad , Ácido Ascórbico , Conducta Animal , Estrés Oxidativo , Sorghum , Tramadol , Animales , Tramadol/farmacología , Estrés Oxidativo/efectos de los fármacos , Masculino , Ácido Ascórbico/farmacología , Ansiedad/prevención & control , Ansiedad/inducido químicamente , Ansiedad/tratamiento farmacológico , Ratas , Conducta Animal/efectos de los fármacos , Antioxidantes/farmacología , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Fármacos Neuroprotectores/farmacología , Extractos Vegetales/farmacología , Ratas Wistar , Analgésicos Opioides/farmacología , Ansiolíticos/farmacología , Aprendizaje por Laberinto/efectos de los fármacos
2.
Heliyon ; 9(9): e20098, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-37810040

RESUMEN

Objective: This study is aimed at comparing differential effect of Levetiracetam (LTC) monotherapy and Carbamazepine (CZP) monotherapy in W omen with epilepsy (WWE) on gonadal hormone. Methods: 87 WWE were recruited comprising randomly of 46 and 41 on CZP and LTC group respectively with diagnosis and classification based on International League Against Epilepsy (ILAE). Reproductive hormones (Luteinizing Hormone (LH), Follicle stimulating hormone, progesterone, estradiol and testosterone) were assayed. National Hospital Seizure Severity Scale (NHSS) and Zung self-reporting depression scale (ZSRDS) were used to assess the seizure severity and the mood respectively. Data was analyzed using Statistical Package for Social Sciences (SPSS) version 20. The Chi-square test was used to compare categorical variables while Student's t-test or its non-parametric equivalent where appropriate were used to compare continuous variables. Results: Clinical characteristics were comparable in both groups except for ZSRDS (p = 0.048), NHSS (p = 0.012) and hip circumference (p = 0.037). The CZP group had a higher ASEX score and proportion of WWE with clinically significant sexual dysfunction (p < 0.001). WWE on LTC had similar hormonal profiles with those on CZP except for a higher median serum testosterone level (p = 0.004), and lower median serum LH (p = 0.006). Age was negatively associated with serum testosterone level for the 25th, 50th, and 75th quartile. However, the differential effect for AED type was only significant for the 25th quartile; with higher values in LTC. Conclusion: The therapeutics implication of lower LH and testosterone levels in the LTC group compared to CZP group need to be explored.

3.
Pharmacol Biochem Behav ; 98(1): 8-11, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21145342

RESUMEN

Methyl jasmonate (MJ) is a hormone released by plants in response to external stress, injury or pathogenic invasions. This present investigation evaluated the antidepressant effect of intraperitoneal doses of MJ in mice. Mice were given MJ in the doses of 10, 25 and 50 mg/kg daily for 7 days and then subjected to forced swim test (FST), tail suspension test (TST) and yohimbine lethality test (YLT). The results showed that MJ produced a significant decrease in the period of immobility in the FST and TST, indicating antidepressant activity. MJ potentiated the toxic effect of yohimbine in the YLT, which further suggests antidepressant property and also indicates facilitatory effect on both serotonergic and noradrenergic systems respectively. However, MJ did not significantly alter the spontaneous motor activity of the animals, which indicates a lack of central nervous system stimulant effect. Taken together, these findings suggest that MJ has antidepressant activity and the mechanisms underlying this effect may involve serotonergic and noradrenergic systems.


Asunto(s)
Acetatos/farmacología , Antidepresivos/farmacología , Ciclopentanos/farmacología , Oxilipinas/farmacología , Acetatos/administración & dosificación , Animales , Antidepresivos/administración & dosificación , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Ciclopentanos/administración & dosificación , Depresión/tratamiento farmacológico , Depresión/fisiopatología , Depresión/psicología , Modelos Animales de Enfermedad , Femenino , Suspensión Trasera/fisiología , Pérdida de Tono Postural/efectos de los fármacos , Pérdida de Tono Postural/fisiología , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Norepinefrina/fisiología , Oxilipinas/administración & dosificación , Reguladores del Crecimiento de las Plantas/farmacología , Serotonina/fisiología , Natación , Yohimbina/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...